All In Biotech

Drug Trial Radar · NCT05405660

A Study of CDX-0159 in Patients With Chronic Inducible Urticaria

: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-ranging Study to Assess the Efficacy and Safety of CDX-0159 in Patients With Chronic Inducible Urticaria

Last checked: Nov 20, 2026Latest source record: Nov 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 196 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

196

Actual

Start

Jun 28, 2022

Primary completion

Jun 12, 2024

Study completion Sep 12, 2025

Sponsor

Lead sponsor
Celldex TherapeuticsIndustry
Sponsor type
Industry
First posted
Jun 6, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the clinical effect, the pharmacodynamics, the safety, and the pharmacokinetics of barzolvolimab (CDX-0159) in patients with Chronic Inducible Urticaria who remain symptomatic despite the use of H1-antihistamines.

Conditions

  • Chronic Inducible Urticaria

Interventions

  • barzolvolimabBiological

    Subcutaneous Administration

  • Matching PlaceboDrug

    Subcutaneous Administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of patients with a negative provocation test at week 12Time frame: From baseline to week 12

Locations

76 sites in 11 countries. Site status is shown where the registry gives one.

  • Clinical Research Center of Alabama

    Birmingham, Alabama

  • Allervie Clinical Research

    Montgomery, Alabama

  • One of a Kind Clinical Research Center, LLC

    Paradise Valley, Arizona

  • Little Rock Allergy & Asthma CRC

    Little Rock, Arkansas

  • Kern Research, Inc

    Bakersfield, California

  • Allergy & Asthma Consultants

    Redwood City, California

  • IMMUNOe Research Centers

    Centennial, Colorado

  • Sarasota Clinical Research

    Sarasota, Florida

  • Treasure Valley Medical Research

    Boise, Idaho

  • Dawes Fretzin Dermatology Group, LLC

    Indianapolis, Indiana

  • Allergy & Asthma Specialists, PSC

    Owensboro, Kentucky

  • Institute for Asthma and Allergy, PC/Department of Clinical Research

    Chevy Chase, Maryland

  • Respiratory Medicine Research Institute of Michigan, PLC

    Ypsilanti, Michigan

  • University of Cincinnati

    Cincinnati, Ohio

  • Allergy Partners of Kerrville

    Kerrville, Texas

  • Allergy Associates of Utah

    Murray, Utah

  • Outpatient Clinic for Individual Practice for Specialized Outpatient

    Razgrad, Bulgaria

  • Medical Center Iskar- EOOD Office of Clinical Allergology

    Sofia, Bulgaria

  • "Medical Center Ekselsior" OOD

    Sofia, Bulgaria

  • "University Multiprofile Hospital for Active Treatment 'Aleksandrovska" EAD, Clinic of Clinical Allergology

    Sofia, Bulgaria

  • Medical Center "SYNEXUS SOFIA", EOOD

    Sofia, Bulgaria

  • University Multiprofile Hospital for Active Treatment "Prof. Dr. Stoyan Kirkovich" AD

    Stara Zagora, Bulgaria

  • Vahlberg & Pild Clinic

    Tallinn, Estonia

  • East Tallin Central Hospital

    Tallinn, Estonia

  • High Technology Hospital Medcenter

    Batumi, Georgia

  • Healthy Future

    Tbilisi, Georgia

  • Center of Allergy and Immunology

    Tbilisi, Georgia

  • Multiprofile Clinic Consilium Medulla

    Tbilisi, Georgia

  • Institute of Allergology IFA

    Berlin, Germany

  • Universitätsklinikum Heidelberg - Dermatologie

    Heidelberg, Germany

  • Universitätsklinikum Augsburg

    Augsburg, Bavaria, Germany

  • LMU Klinikum - Klinik und Poliklinik für Dermatologie und Allergologie DASZ-Dermato-Allergologisches Studien Zentrum

    München, Bavaria, Germany

  • Universitaetsklinikum Giessen u. Marburg GmbH

    Marburg, Hesse, Germany

  • Elbe Klinikum Buxtehude

    Buxtehude, Lower Saxony, Germany

  • Hannover Medical University

    Hanover, Lower Saxony, Germany

  • Klinikum Oldenburg gGmbH - Klinik f. Dermatologie u. Allergologie

    Oldenburg, Lower Saxony, Germany

  • Universitätsklinikum Düsseldorf - Dermatologie

    Düsseldorf, North Rhine-Westphalia, Germany

  • Universitätsklinikum Essen Klinikum f. Dermatologie, Venerologie u. Allergologie Hufelandstr

    Essen, North Rhine-Westphalia, Germany

  • Universitätsklinikum Münster Klinik u. Poliklinik f. Dermatologie

    Münster, North Rhine-Westphalia, Germany

  • Universitätsklinikum Dresden

    Dresden, Saxony, Germany

Showing 40 of 76 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.